BioCentury | May 9, 2016
Financial News

TearLab completes direct public offering

...18.6 million Price: $0.75 (unit) Shares after offering: 52.4 million Placement agent: H.C. Wainwright Note: TearLab...
BioCentury | Feb 15, 2016
Financial News

TearLab withdraws follow-on

...Date announced: 2016-02-09 Type: Follow-on Underwriters: Stephens; Craig-Hallum Capital Group; Feltl; Roth Capital Partners Note: TearLab...
BioCentury | Feb 8, 2016
Financial News

TearLab proposes follow-on

TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Business: Diagnostic Date announced: 2016-02-01 Type: Follow-on To be raised: About $15 million Shares: TBD Price prior: $1.32 Underwriters: Stephens; Craig-Hallum Capital Group; Feltl; Roth Capital Partners Overallotment:...
BioCentury | Oct 7, 2013
Finance

4Q Financial Markets Preview: Room to grow - for now

...Xetra:SCP) 8/1/13 $10.0 $77.4 $143.6 86% BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) 7/31/13 $20.2 $258.9 $428.4 65% TearLab Corp....
BioCentury | Oct 7, 2013
Company News

TearLab management update

TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Business: Diagnostic Hired: Seph Jensen as president and COO, formerly head of surgical marketing at Alcon Inc. , which Novartis AG acquired WIR Staff...
BioCentury | Nov 1, 2010
Clinical News

TearLab Osmolarity System regulatory update

...new current procedural terminology (CPT) code that establishes a CMS reimbursement rate for the company's TearLab...
...and private health insurance programs in the U.S. TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Product: TearLab...
BioCentury | Oct 18, 2010
Clinical News

TearLab Osmolarity System regulatory update

...recommended payment determination for new test codes, including a proposed reimbursement rate, for the company's TearLab...
...The proposed reimbursement rate for the in vitro diagnostic microchip osmometer is $24.01 per eye. TearLab...
...year, FDA granted 510(k) clearance for the system. TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Product: TearLab...
BioCentury | Sep 6, 2010
Company News

TearLab, Abbott sales and marketing update

...TearLab's Osmolarity System in Canada, while TearLab will promote AMO's OTC dry eye products. The TearLab...
...eye disease. The deal includes AMO's Blink Moisturizing Eye Drops. Financial terms were not disclosed. TearLab Corp....
BioCentury | Mar 22, 2010
Financial News

TearLab completes direct public offering

TearLab Corp. (NASDAQ:TEAR), San Diego, Calif. Business: Diagnostic Date completed: 3/15/10 Type: Direct public offering Raised: $5 million Units: 1.6 million Price: $3.22 (unit) Shares after offering: 11.4 million Placement agent: Rodman Note: Each unit...
BioCentury | Jan 18, 2010
Financial News

TearLab completes private placement

TearLab Corp. (NASDAQ:TEAR), San Diego, Calif. Business: Diagnostic Date completed: 1/11/10 Type: Private placement Raised: $1.7 million Shares: 1.9 million Price: $0.92 Shares after offering: 11.8 million Investors: Accredited investors Note: The company also received...
Items per page:
1 - 10 of 13
BioCentury | May 9, 2016
Financial News

TearLab completes direct public offering

...18.6 million Price: $0.75 (unit) Shares after offering: 52.4 million Placement agent: H.C. Wainwright Note: TearLab...
BioCentury | Feb 15, 2016
Financial News

TearLab withdraws follow-on

...Date announced: 2016-02-09 Type: Follow-on Underwriters: Stephens; Craig-Hallum Capital Group; Feltl; Roth Capital Partners Note: TearLab...
BioCentury | Feb 8, 2016
Financial News

TearLab proposes follow-on

TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Business: Diagnostic Date announced: 2016-02-01 Type: Follow-on To be raised: About $15 million Shares: TBD Price prior: $1.32 Underwriters: Stephens; Craig-Hallum Capital Group; Feltl; Roth Capital Partners Overallotment:...
BioCentury | Oct 7, 2013
Finance

4Q Financial Markets Preview: Room to grow - for now

...Xetra:SCP) 8/1/13 $10.0 $77.4 $143.6 86% BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) 7/31/13 $20.2 $258.9 $428.4 65% TearLab Corp....
BioCentury | Oct 7, 2013
Company News

TearLab management update

TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Business: Diagnostic Hired: Seph Jensen as president and COO, formerly head of surgical marketing at Alcon Inc. , which Novartis AG acquired WIR Staff...
BioCentury | Nov 1, 2010
Clinical News

TearLab Osmolarity System regulatory update

...new current procedural terminology (CPT) code that establishes a CMS reimbursement rate for the company's TearLab...
...and private health insurance programs in the U.S. TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Product: TearLab...
BioCentury | Oct 18, 2010
Clinical News

TearLab Osmolarity System regulatory update

...recommended payment determination for new test codes, including a proposed reimbursement rate, for the company's TearLab...
...The proposed reimbursement rate for the in vitro diagnostic microchip osmometer is $24.01 per eye. TearLab...
...year, FDA granted 510(k) clearance for the system. TearLab Corp. (NASDAQ:TEAR; TSX:TLB), San Diego, Calif. Product: TearLab...
BioCentury | Sep 6, 2010
Company News

TearLab, Abbott sales and marketing update

...TearLab's Osmolarity System in Canada, while TearLab will promote AMO's OTC dry eye products. The TearLab...
...eye disease. The deal includes AMO's Blink Moisturizing Eye Drops. Financial terms were not disclosed. TearLab Corp....
BioCentury | Mar 22, 2010
Financial News

TearLab completes direct public offering

TearLab Corp. (NASDAQ:TEAR), San Diego, Calif. Business: Diagnostic Date completed: 3/15/10 Type: Direct public offering Raised: $5 million Units: 1.6 million Price: $3.22 (unit) Shares after offering: 11.4 million Placement agent: Rodman Note: Each unit...
BioCentury | Jan 18, 2010
Financial News

TearLab completes private placement

TearLab Corp. (NASDAQ:TEAR), San Diego, Calif. Business: Diagnostic Date completed: 1/11/10 Type: Private placement Raised: $1.7 million Shares: 1.9 million Price: $0.92 Shares after offering: 11.8 million Investors: Accredited investors Note: The company also received...
Items per page:
1 - 10 of 13